about the community fund for canada’s 150^th

canada’s sesquicentennial is an historic moment with the power to bring people and places together as we dream big about our communities and our country. in the spirit of this moment, the community fund for canada’s 150th will activate a breathtaking array of ideas and activities that will bring out the best that canada has to offer, now and for future generations.

the community fund for canada’s 150th is a small grants program that will support community initiatives in all parts of canada. the fund is a collaboration between canada’s community foundations, the government of canada, and extraordinary leaders from coast to coast to coast.

the fund is based on grassroots leadership, and will take on a local focus and timeline in each community. for more information on the involvement of thunder bay community foundation in the community fund for canada’s 150th, contact mj at (807) 475-7279 or mjgreen@tbcf.org.

 

why is thunder bay community foundation participating in the community fund for canada’s 150th?

partnering with the community fund for canada’s 150th provides thunder bay community foundation with access to matching funding to make more grants to organizations within thunder bay and the district of thunder bay. these grants will be responsive to local priorities, connected to canada’s sesquicentennial and will foster a greater sense of belonging, inclusion and reconciliation in our community.

 

who can apply?

registered charities operating within the thunder bay and the district of thunder bay are eligible to apply through thunder bay community foundation to the community fund for canada’s 150th.

community groups and individuals are welcome to work with a qualified donee to make an application to the fund. in the case of such a collaboration, the qualified donee would submit the application and act as a fiscal agent on behalf of the collaborating parties.

check the canada revenue agency charities listing and list of other qualified donees to find partners in our community that may be interested in collaborating on a project.

please note that the following are not eligible to apply:

• the government of canada (federal government);
• the federal, provincial, and territorial governments;
• the crown; and
• the united nations.

  

how much are the grants worth?

thunder bay community foundation will consider applications for grants of up to $10,000 for projects that meet the eligibility criteria.

the fy16 defense appropriations act provides $16 million (m) to the department of defense parkinson’s research program (prp), formerly the neurotoxin exposure treatment parkinson’s research program (netprp), to support research of exceptional scientific merit leading to an understanding of the cause, prevention, and treatment of the loss of dopaminergic neurons in the substantia nigra that result in parkinson’s disease.  applications to the fy16 prp are being solicited by the u.s. army medical research acquisition activity (usamraa).  the managing agent for the anticipated program announcements/funding opportunities is the congressionally directed medical research programs (cdmrp).

fy16 prp program announcements and general application instructions for the following award mechanisms are posted on the grants.gov website. 

important:  the prp seeks to focus applications and direct funding by providing focus areas to address the critical needs in parkinson’s disease research.  applications must address at least one of the focus areas noted below: 

·         studies of the neurovascular unit (including neurons, glia, the microvasculature, and the blood-brain barrier) in parkinson’s disease and changes associated with its treatment.  (for both award mechanisms.)

·         identification and evaluation of mechanisms in early parkinson’s disease involving olfactory, microbiome, gastrointestinal, and/or autonomic nervous systems.  (for both award mechanisms.)

·         mechanisms of neuroplasticity and compensation in parkinson’s disease, such as influences of sleep, exercise, and diet.  (for both award mechanisms.)

·         underlying factors influencing the progression in parkinson’s disease in specific community-based populations (e.g., veterans) to identify the heterogeneity of parkinson’s disease.  (for impact award applications only.)

 

http://cdmrp.army.mil/funding/prp.shtml

 

focused idea award - letter of intent due november 9, 2016

assistant professor level or above (or equivalent) 

·         supports conceptually innovative research that could lead to critical discoveries in parkinson’s disease research and/or patient care.

·         strong, appropriately qualified pi and research team.  

·         must address at least one of the fy16 prp focus areas.

·         the application must articulate how the proposed research impacts the parkinson’s disease population.

·         preliminary data are not required.

·         submission of a letter of intent is required prior to full application submission. 

·         clinical trials are not allowed.

·       maximum funding of $350,000 for direct costs (plus indirect costs)

·       maximum period of performance is 3 years.

 

impact award- letter of intent due november 9, 2016

assistant professor level or above (or equivalent) 

·        preproposal is required; application submission is by invitation only.

·        supports high-impact, potentially high-risk, studies that address at least one of the fy16 prp focus areas.

·        potential impact of research may be near-term or long-term, but it must be significant and go beyond an incremental advancement.

·        proposed projects may include basic, translational, or clinical research not including clinical trials.

·        preliminary data to support feasibility are required.

·        partnering pi option:

o    provides a higher level of funding to support synergistic partnerships between two or three independent investigators collaborating on a single application.

pis are expected to demonstrate within the application the synergistic components that will significantly advance the project such that the research outcomes could not otherwise be accomplished through independent efforts of a single pi.

individual pis:

·       maximum funding of $3 million (m) for total costs (includes direct and indirect)

·       maximum period of performance is 4 years

partnering pi option:

·       maximum funding of $5m for total costs (includes direct and indirect costs)

·       maximum period of performance is 4 years

a pre-application is required and must be submitted through the electronic biomedical research application portal (ebrap) at https://ebrap.org prior to the pre-application deadline.  all applications must conform to the final program announcements and general application instructions that will be available for electronic downloading from the grants.gov website.  the application package containing the required forms for each award mechanism will also be found on grants.gov.  a listing of all cdmrp funding opportunities can be obtained on the grants.gov website by performing a basic search using cfda number 12.420. 

 

applications must be submitted through the federal government’s single-entry portal, grants.gov.  for email notification when program announcements are released go to the cdmrp website (http://cdmrp.army.mil) and select subscribe to funding opportunities & program communications.  for more information about the prp or other cdmrp-administered programs, please visit the cdmrp website (http://cdmrp.army.mil).

point of contact:

cdmrp help desk
301-682-5507
help@ebrap.org

veterans affairs canada is seeking a qualified research team to design and conduct an 18-month qualitative pilot study to better understand how equine-assisted therapy might assist canadian armed forces (caf) veterans and their family members in managing service-related mental health conditions.

the canadian institute for military and veteran health research (cimvhr) has entered into partnership with the government of canada to procure research and development services related to the mental, social and physical wellbeing of active military members, veterans and their families. cimvhr is seeking notices of interest from qualified researchers to enter into a contract with cimvhr to produce this work.

the successful team will have the following minimum qualifications:

• one or more senior investigators with an md or phd in a relevant discipline;
• experience and knowledge of research in the domain of mental health;
• experience and capabilities in conducting qualitative research;
• demonstrated experience in research design and analysis;
• a faculty appointment at one of cimvhr’s partner universities (a list of partner universities is available at https://cimvhr.ca/university-partners);
• be able to meet project deliverables within stated timelines
• work experience with and or knowledge of the unique needs of canadian armed forces veterans is an asset;
• please see the attached statement of work (sow) for more details.

the fy16 defense appropriations act provides $15 million (m) to the department of defense peer reviewed alzheimer’s research program (prarp) to support research which addresses the long-term consequences of traumatic brain injury (tbi) as they pertain to alzheimer’s disease (ad) and related dementias (adrd). the research impact will benefit the military, veteran, and civilian communities. the prarp’s mission is therefore devoted to (1) understanding the association between tbi and ad/adrd; and (2) reducing the burden on affected individuals and caregivers, especially in the military and veteran communities. as directed by the office of the assistant secretary of defense for health affairs, the defense health agency, research, development, and acquisition (dha rda) directorate manages the defense health program (dhp) research, development, test, and evaluation (rdt&e) appropriation. the managing agent for the anticipated program announcements/funding opportunities is the congressionally directed medical research programs (cdmrp).

fy16 prarp program announcements and general application instructions for the following award mechanisms are posted on the grants.gov website. 

fy16 prarp overarching challenges and focus areas:

 

all applications for the fy16 prarp funding opportunities must address at least one of the following fy16 overarching challenges. the fy16 overarching challenges will be mechanism-specific.

the prarp fy16 overarching challenges are as follows:

paucity of research resources:  the paucity of research resources to examine the interrelationship between tbi and subsequent ad/adrd for the military, veteran, and civilian communities.

paucity of clinical studies:  the paucity of clinical or epidemiological studies to examine the interrelationship between tbi and subsequent ad/adrd for the military, veteran, and civilian communities.

diagnostic technologies, tests, biomarkers, or devices:  the need for technologies, tests, or devices to detect the progression to ad/adrd subsequent to tbi.

quality of life:  the need for technologies, assessments, interventions, or devices to benefit individuals living with the common symptoms of tbi and ad/adrd.

caregiver burden:  the need for technologies, assessments, interventions, or devices with the goal of reducing burden for caregivers of individuals living with the common symptoms of tbi and ad/adrd.

epidemiology:  the paucity of epidemiology research to examine the interrelationship between tbi and subsequent ad/adrd for the military, veteran, and civilian communities

in addition to addressing one or more of the specified fy16 overarching challenges, applications should also address at least one of the following fy16 focus areas in support of the fy16 overarching challenges. an application that proposes research outside of the fy16 focus areas is acceptable, as long as the applicant provides a strong rationale. the focus areas will be mechanism-specific.

the prarp fy16 focus areas are as follows:

genomics/proteomics:  studies or technologies (e.g., genetic, proteomic, and epigenetic strategies) intended to characterize neurological change(s) associated with tbi and subsequent ad/adrd. in addition, relevant technologies or tests may be considered under this focus area.

mechanisms of pathogenesis: identification of contributing mechanisms (e.g., pathology of tau, non-neuronal cells, inflammatory factors, and vascular contributions) associated with tbi and subsequent ad/adrd pathogenesis.

care interventions and quality of life:  research intended to stabilize or improve the quality of life of those affected by the common symptoms of tbi and ad/adrd.  examples of research in this focus area include: identification and management of co-morbidities and modifiable risk factors (e.g., sleep apnea, obesity); cognitive training interventions; studies of health and wellness and behavioral interventions.

caregiver support:  research intended to reduce the burden of care on the caregiver for individuals affected by the common symptoms of tbi and ad/adrd.  examples of research in this focus area include: caregiver training, home-based support, behavioral interventions, and relationship interventions.

diagnostics and biomarkers:  development of strategies to characterize neurological changes associated with tbi and subsequent ad/adrd (e.g., fluid based, imaging, physiological, and clinical approaches).

novel target identification:  basic research (non-human) directly leading to the identification of new targets for the development of existing or new investigational medicines, drugs, or agents.

epidemiological research:  research focusing on the incidence, distribution, and other factors relating to the health of individuals affected by tbi and subsequent ad/adrd.

the following is a summary of the fy16 prarp program announcements. four award mechanisms will be offered for fy16. this pre-announcement should not be construed as an obligation by the government.

 

http://cdmrp.army.mil/funding/prarp.shtml

 

convergence science research award – preproposal due august 17, 2016

principal investigators (pis) at or above the level of assistant professor (or equivalent) from any field or discipline, who seek to bring their expertise to address the prarp’s mission; the research team must demonstrate traumatic brain injury (tbi)/alzheimer’s disease (ad) and ad-related dementias (adrd) experience.

 

supports efforts to generate research resources, tools, or novel research efforts for researchers and/or practitioners in health sciences

 

applications must address one or more of the following fy16 prarp overarching challenges:

·     paucity of research resources

·     paucity of clinical studies

·     diagnostic technologies, tests, or devices

·     epidemiology

 

applications should address at least one of the following fy16 prarp focus areas:

·     genomics/proteomics

·     mechanisms of pathogenesis

·     diagnostics and biomarkers

·     novel target identification

·     epidemiological research

 

research considering pharmacologic interventions is specifically discouraged under this mechanism.

 

preliminary data, while not required, are encouraged.

 

preproposal submission is required; application submission is by invitation only.

 

·         maximum funding of $500,000 for direct costs (plus indirect costs)

·         maximum period of performance is 3 years

indirect costs may be proposed in accordance with the institution's rate agreement

 

quality of life research award – preproposal due august 17, 2016

principal investigators (pis) at or above the level of assistant professor (or equivalent) from any field or discipline, who seek to bring their expertise to address the prarp’s mission; the research team must demonstrate traumatic brain injury (tbi)/alzheimer’s disease (ad) and ad-related dementias (adrd) experience.

 

supports preclinical, basic, epidemiological, or quality-of-life research to alleviate or characterize the common symptoms of tbi and ad/adrd

 

level i: supports investigator-initiated research that may be high-risk and/or high-gain.

 

level ii: supports advanced studies that may be multidisciplinary in nature, and/or have multiple collaborators.

 

applications must address one or more of the following fy16 prarp overarching challenges:

·      paucity of clinical studies

·      quality of life

·      caregiver burden

 

applications should address at least one of the following fy16 prarp focus areas:

·      care interventions and quality of life

·      caregiver support

·      diagnostics and biomarkers

·      epidemiological research

 

research considering pharmacologic interventions is specifically discouraged under this mechanism.

 

preliminary data, while not required, are encouraged.

 

preproposal submission is required; application submission is by invitation only.

 

level i:

·         funding limit is $500,000 direct costs.

·         maximum period of performance is 3 years.

·         indirect costs may be proposed inaccordance with the institution's rate agreement.

level ii:

·         funding limit is $1.9m total costs.

·         maximum period of performance is 4 years.

indirect costs may be proposed in accordance with the institution’s rate agreement.

 

epidemiology of military risk factors award – preproposal due august 17, 2016

principal investigators (pis) at or above the level of assistant professor (or equivalent) from any field or discipline, who seek to bring their expertise to address the prarp’s mission; the research team must demonstrate traumatic brain injury (tbi)/alzheimer’s disease (ad) and ad-related dementias (adrd) experience.

 

supports investigations of the etiology and epidemiology of military-related tbi and ad/adrd

 

applications must address one or more of the following fy16 prarp overarching challenges:

·      paucity of research resources

·      paucity of clinical studies

·      diagnostic technologies, tests, biomarkers, or devices

·      epidemiology

 

applications should address at least one of the following fy16 prarp focus areas:

·      genomics/proteomics

·      diagnostics and biomarkers

·      epidemiological research

 

research considering pharmacologic interventions is specifically discouraged under this mechanism.

 

preliminary data, while not required, are encouraged.

 

preproposal submission is required; application submission is by invitation only.

 

important note:  applications must detail and demonstrate expedited access to a well-defined, already identified study cohort.

·         funding limit is $2.5m total costs.

·         maximum period of performance is 4 years.

indirect costs may be proposed in accordance with the institution’s rate agreement.

 

translational research partnership award – preproposal due august 17, 2016

principal investigators (pis) at or above the level of assistant professor (or equivalent) from any field or discipline, who seek to bring their expertise to address the prarp’s mission; the research team must demonstrate traumatic brain injury (tbi)/alzheimer’s disease (ad) and ad-related dementias (adrd) experience.  one partner must be a researcher and the other must be a clinician.

 

supports creation of an avenue for partnerships between clinicians and research scientists to address a translational research problem or question in a manner that would be unachievable through separate efforts

 

supports the development of translational research collaborations between two independent, faculty-level (or equivalent) investigators

 

must include clearly stated plans for interactions between the principal investigators (pis) and institutions involved. the plans must include communication, coordination of research progress and results, and data transfer

 

clinical trials not allowed.

 

applications must address one or more of the following fy16 prarp overarching challenges:

·     paucity of research resources

·     diagnostic technologies, tests, biomarkers, or devices

·     quality of life

·     caregiver burden

 

applications should address at least one of the following fy16 prarp focus areas:

·     genomics/proteomics

·     mechanisms of pathogenesis

·     care interventions and quality of life

·     caregiver support

·     diagnostics and biomarkers

 

research considering pharmacologic interventions is specifically discouraged under this mechanism.

 

preliminary data are required.

 

preproposal submission is required; application submission is by invitation only.

 

·         funding limit is $1.3m total costs.

·         maximum period of performance is 3 years.

indirect costs may be proposed in accordance with the institution’s rate agreement.

a pre-application is required and must be submitted through the electronic biomedical research application portal (ebrap) at https://ebrap.org prior to the pre-application deadline. all applications must conform to the final program announcements and general application instructions that will be available for electronic downloading from the grants.gov website.  the application package containing the required forms for each award mechanism will also be found on grants.gov.  a listing of all cdmrp funding opportunities can be obtained on the grants.gov website by performing a basic search using cfda number 12.420. 

 

applications must be submitted through the federal government’s single-entry portal, grants.gov.  for email notification when program announcements are released go to the cdmrp website (http://cdmrp.army.mil) and select subscribe to funding opportunities & program communications.  for more information about the prarp or other cdmrp-administered programs, please visit the cdmrp website (http://cdmrp.army.mil).

point of contact:

cdmrp help desk
301-682-5507
help@ebbrap.org

fisheries and oceans canada’s (dfo) national contaminants advisory group (ncag) provides scientific information and advice to dfo and other government departments on priority issues related to the biological effects of contaminants on aquatic organisms. one of the group’s functions is to fund research on priority contaminants issues.

 

i am pleased to announce that the dfo-ncag 2016 call for proposals is now open.

 

through this call for proposals, dfo is seeking research proposals that will ultimately enhance the department’s scientific knowledge and support evidence-based decision-making on the biological effects of contaminants in four theme areas: aquaculture therapeutants; pesticides; oil and gas; contaminants and issues of emerging concern.

 

researchers from recognized canadian post-secondary academic institutions and canadian non-governmental not-for-profit research organizations are eligible and encouraged to apply.

 

the application deadline is september 30, 2016, 11:59 pm (pacific daylight time).

 

please forward this message to researchers within your organisation who may be interested.

 

for further information on the application process, research priorities, and the funding horizon, please visit the ncag website .

 

please direct all inquiries to ncag-gncc@dfo-mpo.gc.ca.

 

thank you for your interest,

the canadian forces health services group is seeking an expert researcher to conduct a prospective cohort study of canadian armed forces (caf) personnel and veterans experiencing ptsd to identify neural activation patterns and biomolecular signatures associated with the processing of traumatic memories, which may stem in part from situations they experienced during deployment(s) that conflicted with their beliefs about what is and is not morally/ethically appropriate (moral injury).

the canadian institute for military and veteran health research (cimvhr) has entered into partnership with the government of canada to procure research and development services related to the mental, social and physical wellbeing of active military members, veterans and their families. cimvhr is seeking notices of interest from qualified researchers or a research team to enter into a contract with cimvhr to produce this work.

the fy16 defense appropriations act provides $30 million (m) to the department of defense spinal cord injuryresearch program (scirp) to support innovative, high-impact spinal cord injury research.  as directed by the office of the assistant secretary of defense for health affairs, the defense health agency, research, development, and acquisition (dha rda) directorate manages the defense health program (dhp) research, development, test, and evaluation (rdt&e) appropriation.  the managing agent for the anticipated program announcements/funding opportunities is the congressionally directed medical research programs (cdmrp).

fy16 scirp program announcements and general application instructions for the following award mechanism is posted on the grants.gov website. 

 

http://cdmrp.army.mil/funding/scirp.shtml

 

clinical research development award – letter of intent due september 7, 2016

independent investigators at all academic levels (or equivalent)

·    preproposal is required; application submission is by invitation only.

·    fund research that will establish the necessary collaborations and develop the necessary research resources that will serve as a foundation for investigator-initiated clinical research.

·    clinical trials not allowed.

·      maximum funding of $100,000 for direct costs (plus indirect costs)

·      maximum period of performance is 1 year

a pre-application is required and must be submitted through the electronic biomedical research application portal (ebrap) at https://ebrap.org prior to the pre-application deadline.  all applications must conform to the final program announcements and general application instructions that will be available for electronic downloading from the grants.gov website.  the application package containing the required forms for each award mechanism will also be found on grants.gov.  a listing of all cdmrp funding opportunities can be obtained on the grants.gov website by performing a basic search using cfda number 12.420. 

 

applications must be submitted through the federal government’s single-entry portal, grants.gov.   for email notification when program announcements are released go to the cdmrp website (http://cdmrp.army.mil) and select subscribe to funding opportunities & program communications.  for more information about the scirp or other cdmrp-administered programs, please visit the cdmrp website (http://cdmrp.army.mil).

point of contact:

cdmrp help desk
301-682-5507
help@ebrap.org

biomedical research grants provide financial support to medical researchers to assist in defraying the operating costs of research, which may include the purchase of materials, supplies and equipment and the payment of laboratory assistants.

grants are available for one, two or three years, commencing july 1, for up to $50,000 per year. the research must be carried out in canada.

2017 competition - important dates 

competition (two stage process)	deadline
registration form	september 01, 2016
full application	october 01, 2016

 

innovation grants have been created to support innovative, creative problem solving in cancer research. as competition for grant funding increases, peer review panels become more conservative and risk averse, emphasizing feasibility more than innovation. the goal of this ccsri grant program is to support unconventional concepts, approaches or methodologies to address problems in cancer research. innovation projects will include elements of creativity, curiosity, investigation, exploration and opportunity. successful projects may be based on “high risk” ideas, but will have the potential for “high reward” (i.e. to significantly impact our understanding of cancer and generate new approaches to combat the disease by introducing novel ideas into use or practice).

it is hoped that this grant program will accelerate the introduction of innovation into the entire cancer research system and contribute to the scientific idea pipeline. significant findings from investigators funded by innovation grants may be developed further through ccsri "innovation to impact" grants or operating grants offered by other agencies.